Back

Kidney parameters of the EMPAGHF cohort.

28 August 2022 (14:37 - 14:56)
Organised by:
Congress Presentation Part of: Latest science in heart failure 2 Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Jurgen Bogoviku

University hospital Jena, Jena (Germany)

3 More presentations in this session

Presentation thumbnail
SERVE - Tadalafil for patients with systemic right ventricles.
Professor M. Schwerzmann (Ottawa, CA)
Slides Video
Presentation thumbnail
GCHF - LVEF and RV size .
Doctor D. Leong (Hamilton, CA)
Slides Video
Presentation thumbnail
5-year Survival with LVAD Therapy in MOMENTUM 3
Professor M. Mehra (Boston, US)
Slides Video

Access the full session

Session thumbnail
Latest science in heart failure 2
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 14:37 CET
You may be interested in
thumbnail
Congress Presentation
Impact of a urinary-sodium driven algorithm to optimize natriuresis in patients with ADHF: the FASTR trial
thumbnail
Congress Presentation
Acute diuretic effect of empagliflozin in de novo heart failure: a secondary analysis of the EMPAG-HF trial
thumbnail
Congress Presentation
Renal function in patients with acute decompensated de novo heart failure treated with the SGLT2 inhibitor empagliflozin: a secondary analysis of the EMPAG-HF trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources